Removing Barriers. Expanding Capacity. How Source BioScience Built a Scalable Digital Pathology Network with HALO AP®
Read How Source BioScience Built a Scalable Digital Pathology Network with HALO AP®. Supporting over 90 NHS Trusts.
HALO AP
Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership
ALBUQUERQUE, N.M, October 15, 2026 — Indica Labs, the trusted global leader in AI-powered digital pathology, today announced a significant expansion of its strategic partnership with NeoGenomics, a leading provider of oncology diagnostic solutions that enable precision medicine. The expanded collaboration modernizes NeoGenomics enterprise digital pathology infrastructure, accelerates AI adoption across clinical operations and biomarker analysis, and establishes a joint development framework for the next generation of companion diagnostic (CDx) solutions.
Voicebrook Announces Digital Pathology Integration with Indica Labs, Delivering Automated AI Biomarker Reporting and Hands-Free Navigation
Roslyn Heights, NY and Albuquerque, NM, September 22, 2026 – Voicebrook, the leader in pathology workflow automation, driving reporting end to end, today announced a new integration partnership with Indica Labs, the trusted global leader in AI-powered digital pathology . The integration connects Voicebrook’s VoiceOver PRO reporting workflow to the Indica Labs HALO AP platform, giving pathologists hands-free control of digital slide review while allowing HALO Clinical AI-generated biomarker results to flow automatically into the appropriate CAP cancer protocol checklist.
Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom
Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source Bioscience’s successful expansion of its digital pathology operation powered by HALO AP®. Since going live at Nottingham headquarters in October 2025, the organization has demonstrated how an interoperable, scanner-agnostic enterprise platform can eliminate one of the greatest barriers to large-scale digital pathology outsourcing while enabling rapid laboratory growth.
Automating Tissue Macro-Dissection with Insight
1 October 2026 | Learn how NCI teamed up with Indica Labs and Xyall to develop an end-to-end solution for automating tissue macro-dissection
Automating Tissue Macro-Dissection with Insight Read More »
Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI
In this blog post, we’ll discuss some of the exciting new features and functionalities in the latest release of HALO AP®, the CE-IVDR marked, AI-powered enterprise digital pathology platform from Indica Labs.
Zero-Click Breast IHC Scoring Is Here: What’s New in HALO Breast IHC AI Read More »
HALO AP 2.5: Scaling Digital Pathology with Intelligent Workflow Orchestration
In this blog post, we’ll discuss some of the exciting new features and functionalities in the latest release of HALO AP®, the CE-IVDR marked, AI-powered enterprise digital pathology platform from Indica Labs.
HALO AP 2.5: Scaling Digital Pathology with Intelligent Workflow Orchestration Read More »
HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability
Albuquerque, NM, July 14, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced a new software release designed to streamline and scale digital pathology workflows through enhanced automation, collaboration, and system transparency.
HALO AP® 2.5
HALO AP® AI Powered, Pathologist Driven The CE-IVDR marked, AI-powered image management system built to digitize clinical pathology workflows and allow pathologists to work anytime,
Indica Labs Expands into Prostate Cancer, Improving NGS ConfidenceThrough Precise Tumor Quantification
Albuquerque, NM, June 30, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the launch of Prostate Macrodissect AI, a clinically validated algorithm designed to automate and quantify tumor content in FFPE prostate tissue specimens. Prostate Macrodissect AI is designed to operate in concert with Indica Labs’ broader HALO Clinical AI suite, enabling laboratories to build end-to-end AI-powered prostate cancer workflows from automated tumor detection and Gleason grading assistance through to optimized macrodissection and genomic test preparation within a single, validated digital pathology platform.